Wall Street pauses record-setting rally as FedEx shares tumble
By April Joyner NEW YORK (Reuters) - The S&P 500 ended a five-day winning streak on Wednesday as investors' optimism about global economic growth was countered by a steep drop in FedEx Corp shares, but the benchmark index managed to hover near all-time highs.
By April Joyner
NEW YORK (Reuters) - The S&P 500 ended a five-day winning streak on Wednesday as investors' optimism about global economic growth was countered by a steep drop in FedEx Corp
FedEx shares tumbled 10.0% after the U.S. parcel delivery company cut its fiscal 2020 profit forecast on heavy expenses, slowing global trade and fallout from its breakup with Amazon.com Inc
The decline in FedEx shares weighed on the blue-chip Dow industrials. Shares of rival package delivery company United Parcel Service Inc
But the Nasdaq notched a record closing high for a fifth straight session.
Even with Wednesday's nominal losses on the S&P 500, analysts said market sentiment remained largely upbeat following last week's announcement of an initial U.S.-China trade agreement. Earlier in the session, the S&P 500 hit its fifth consecutive record high.
"Investors have gotten much more comfortable with the path of things that have been dark clouds over the market," said Wayne Wicker, chief investment officer at Vantagepoint Investment Advisers in Washington. "This is just somewhat of a pause after having such a strong run."
The market largely shrugged off the likely impeachment of U.S. President Donald Trump as the House of Representatives geared up for a historic vote later in the day on two charges accusing Trump of abusing his power and obstructing Congress.
Impeachment would have little effect on the factors most influential on U.S. markets, said Shannon Saccocia, chief investment officer at Boston Private. "It doesn't change what the Fed does," she said. "It doesn't change what happens from a China perspective."
The Dow Jones Industrial Average <.DJI> fell 27.88 points, or 0.1%, to 28,239.28, the S&P 500 <.SPX> lost 1.38 points, or 0.04%, to 3,191.14, and the Nasdaq Composite <.IXIC> added 4.38 points, or 0.05%, to 8,827.74.
The small-cap Russell 2000 <.RUT> hit its highest level in 14 months and ended 0.25% higher.
Advancing issues outnumbered declining ones on the NYSE by a 1.55-to-1 ratio; on Nasdaq, a 1.03-to-1 ratio favoured advancers.
The S&P 500 posted 40 new 52-week highs and no new lows; the Nasdaq Composite recorded 166 new highs and 59 new lows.
Volume on U.S. exchanges was 7.72 billion shares, compared to the 6.95 billion average for the full session over the last 20 trading days.
(Reporting by April Joyner; Additional reporting by Uday Sampath, C Nivedita and Abhishek Manikandan in Bengaluru; Editing by Leslie Adler)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
DAKAR (Reuters) - More than 20 people, including children, were killed in an airstrike during a wedding ceremony in central Mali on Sunday, a health worker with knowledge of the attack told Reuters. (Reporting By Edward McAllister; Editing by Aaron Ross)
By Estelle Shirbon and Natalie Thomas LONDON (Reuters) - Britain began its third COVID-19 lockdown on Tuesday with the government calling for one last major national effort to defeat the spread of a virus that has infected an estimated one in 50 citizens before mass vaccinations turn the tide. Finance minister Rishi Sunak announced a new package of business grants worth 4.6 billion pounds ($6.2 billion) to help keep people in jobs and firms afloat until measures are relaxed gradually, at the earliest from mid-February but likely later
By Dominique Vidalon and Sudip Kar-Gupta PARIS (Reuters) - France is stepping up its COVID-19 vaccine rollout by widening the first target group to include more health workers and simplifying a cumbersome process to deliver shots more quickly, Health Minister Olivier Veran said on Tuesday. France's inoculation campaign got off to a slow start, hampered in part by red tape and President Emmanuel Macron's decision to tread warily in one of the world's most vaccine-sceptical countries. France has fallen behind neighbours such as Britain and Germany, and the president is now demanding the vaccination programme be expedited